BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 34384486)

  • 1. GDF11 enhances therapeutic functions of mesenchymal stem cells for angiogenesis.
    Zhang C; Lin Y; Zhang K; Meng L; Hu X; Chen J; Zhu W; Yu H
    Stem Cell Res Ther; 2021 Aug; 12(1):456. PubMed ID: 34384486
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Growth differentiation factor 11 promotes differentiation of MSCs into endothelial-like cells for angiogenesis.
    Zhang C; Lin Y; Liu Q; He J; Xiang P; Wang D; Hu X; Chen J; Zhu W; Yu H
    J Cell Mol Med; 2020 Aug; 24(15):8703-8717. PubMed ID: 32588524
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Self-assembled GFFYK peptide hydrogel enhances the therapeutic efficacy of mesenchymal stem cells in a mouse hindlimb ischemia model.
    Huang A; Liu D; Qi X; Yue Z; Cao H; Zhang K; Lei X; Wang Y; Kong D; Gao J; Li Z; Liu N; Wang Y
    Acta Biomater; 2019 Feb; 85():94-105. PubMed ID: 30550934
    [TBL] [Abstract][Full Text] [Related]  

  • 4. GDF11 enhances therapeutic efficacy of mesenchymal stem cells for myocardial infarction via YME1L-mediated OPA1 processing.
    Zhao Y; Zhu J; Zhang N; Liu Q; Wang Y; Hu X; Chen J; Zhu W; Yu H
    Stem Cells Transl Med; 2020 Oct; 9(10):1257-1271. PubMed ID: 32515551
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Profound Actions of an Agonist of Growth Hormone-Releasing Hormone on Angiogenic Therapy by Mesenchymal Stem Cells.
    Ma Q; Xia X; Tao Q; Lu K; Shen J; Xu Q; Hu X; Tang Y; Block NL; Webster KA; Schally AV; Wang J; Yu H
    Arterioscler Thromb Vasc Biol; 2016 Apr; 36(4):663-672. PubMed ID: 26868211
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hypoxia pretreatment improves the therapeutic potential of bone marrow mesenchymal stem cells in hindlimb ischemia via upregulation of NRG-1.
    Peng X; Liang B; Wang H; Hou J; Yuan Q
    Cell Tissue Res; 2022 Apr; 388(1):105-116. PubMed ID: 35091805
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Overexpression of Gremlin1 in Mesenchymal Stem Cells Improves Hindlimb Ischemia in Mice by Enhancing Cell Survival.
    Xiang Q; Hong D; Liao Y; Cao Y; Liu M; Pang J; Zhou J; Wang G; Yang R; Wang M; Xiang AP
    J Cell Physiol; 2017 May; 232(5):996-1007. PubMed ID: 27579673
    [TBL] [Abstract][Full Text] [Related]  

  • 8. VCAM-1+ placenta chorionic villi-derived mesenchymal stem cells display potent pro-angiogenic activity.
    Du W; Li X; Chi Y; Ma F; Li Z; Yang S; Song B; Cui J; Ma T; Li J; Tian J; Yang Z; Feng X; Chen F; Lu S; Liang L; Han ZB; Han ZC
    Stem Cell Res Ther; 2016 Apr; 7():49. PubMed ID: 27044487
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparative analysis of mouse bone marrow and adipose tissue mesenchymal stem cells for critical limb ischemia cell therapy.
    Nammian P; Asadi-Yousefabad SL; Daneshi S; Sheikhha MH; Tabei SMB; Razban V
    Stem Cell Res Ther; 2021 Jan; 12(1):58. PubMed ID: 33436054
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vivo efficacy of endothelial growth medium stimulated mesenchymal stem cells derived from patients with critical limb ischemia.
    Al-Rifai R; Nguyen P; Bouland N; Terryn C; Kanagaratnam L; Poitevin G; François C; Boisson-Vidal C; Sevestre MA; Tournois C
    J Transl Med; 2019 Aug; 17(1):261. PubMed ID: 31399109
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Enhancement of angiogenic effects by hypoxia-preconditioned human umbilical cord-derived mesenchymal stem cells in a mouse model of hindlimb ischemia.
    Han KH; Kim AK; Kim MH; Kim DH; Go HN; Kim DI
    Cell Biol Int; 2016 Jan; 40(1):27-35. PubMed ID: 26222206
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hepatocyte growth factor gene-modified bone marrow-derived mesenchymal stem cells transplantation promotes angiogenesis in a rat model of hindlimb ischemia.
    Su GH; Sun YF; Lu YX; Shuai XX; Liao YH; Liu QY; Han J; Luo P
    J Huazhong Univ Sci Technolog Med Sci; 2013 Aug; 33(4):511-519. PubMed ID: 23904370
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Protein profiling and angiogenic effect of hypoxia-cultured human umbilical cord blood-derived mesenchymal stem cells in hindlimb ischemia.
    Han KH; Kim AK; Kim MH; Kim DH; Go HN; Kang D; Chang JW; Choi SW; Kang KS; Kim DI
    Tissue Cell; 2017 Dec; 49(6):680-690. PubMed ID: 28958480
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bone marrow mesenchymal stem cell-derived endothelial cells increase capillary density and accelerate angiogenesis in mouse hindlimb ischemia model.
    Yao Z; Liu H; Yang M; Bai Y; Zhang B; Wang C; Yan Z; Niu G; Zou Y; Li Y
    Stem Cell Res Ther; 2020 Jun; 11(1):221. PubMed ID: 32513272
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A novel platelet lysate hydrogel for endothelial cell and mesenchymal stem cell-directed neovascularization.
    Robinson ST; Douglas AM; Chadid T; Kuo K; Rajabalan A; Li H; Copland IB; Barker TH; Galipeau J; Brewster LP
    Acta Biomater; 2016 May; 36():86-98. PubMed ID: 26961805
    [TBL] [Abstract][Full Text] [Related]  

  • 16. SDF-1 secreted by mesenchymal stem cells promotes the migration of endothelial progenitor cells via CXCR4/PI3K/AKT pathway.
    Wang X; Jiang H; Guo L; Wang S; Cheng W; Wan L; Zhang Z; Xing L; Zhou Q; Yang X; Han H; Chen X; Wu X
    J Mol Histol; 2021 Dec; 52(6):1155-1164. PubMed ID: 34642827
    [TBL] [Abstract][Full Text] [Related]  

  • 17. PEP-1-CAT-transduced mesenchymal stem cells acquire an enhanced viability and promote ischemia-induced angiogenesis.
    Zhang L; Dong XW; Wang JN; Tang JM; Yang JY; Guo LY; Zheng F; Kong X; Huang YZ; Chen SY
    PLoS One; 2012; 7(12):e52537. PubMed ID: 23285080
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Angiogenic effects despite limited cell survival of bone marrow-derived mesenchymal stem cells under ischemia.
    Hoffmann J; Glassford AJ; Doyle TC; Robbins RC; Schrepfer S; Pelletier MP
    Thorac Cardiovasc Surg; 2010 Apr; 58(3):136-42. PubMed ID: 20379963
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A nitric oxide-releasing hydrogel for enhancing the therapeutic effects of mesenchymal stem cell therapy for hindlimb ischemia.
    Zhang K; Chen X; Li H; Feng G; Nie Y; Wei Y; Li N; Han Z; Han ZC; Kong D; Guo Z; Zhao Q; Li Z
    Acta Biomater; 2020 Sep; 113():289-304. PubMed ID: 32663662
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Paracrine factors released by GATA-4 overexpressed mesenchymal stem cells increase angiogenesis and cell survival.
    Li H; Zuo S; He Z; Yang Y; Pasha Z; Wang Y; Xu M
    Am J Physiol Heart Circ Physiol; 2010 Dec; 299(6):H1772-81. PubMed ID: 20870802
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.